Image alt Bayer Logo Bayer Logo Bayer Logo Bayer Logo

Disease insights

Understanding and defining the characteristics of retinal diseases are crucial steps to ensuring optimal diagnosis and treatment. Clinical decisions should be guided by disease characteristics and should aim to achieve an optimal outcome. In this resource zone, we provide guidance on the characteristics and definitions of various retinal diseases:

  • The definition and pathogenesis of pachychoroid in nAMD/PCV
  • Characterization of AMD subtypes to optimize treatment outcomes

Pachychoroid: current concepts on clinical features and pathogenesis

The term “pachychoroid” refers to a phenotype in which functional and structural changes within the choroid are thought to play a key role in the pathogenesis of a spectrum of related retinal disorders known as the “pachychoroid spectrum”.


The Vision Academy’s newly published article in Graefe’s Archive for Clinical and Experimental Ophthalmology describes the commonalities that are present across pathologies included in the pachychoroid spectrum, and discusses current knowledge on the examination, monitoring, and management of these disorders.

Read the Vision Academy publication on the current concepts and clinical features and pathogenesis of pachychoroid Read the Vision Academy Viewpoint on the current concepts on clinical features and pathogenesis of pachychoroid

Characterization of MNV subtypes in nAMD to optimize treatment outcomes

Defining and differentiating the subtypes of macular neovascularization (MNV) is important in the management of neovascular age-related macular degeneration (nAMD) in order to ensure optimal response to treatment. A clearly defined classification of MNV can help to predict functional and anatomical outcomes after treatment, thereby facilitating patient management. The Vision Academy has provided expert consensus on the definitions and characteristics of MNV subtypes, and recommendations on differentiating between and tailoring treatment to specific subtypes.

 

Watch the tutorial video describing the pathophysiology of nAMD and the characterization of its subtypes or click the link below to access the Vision Academy publication on characterization of MNV subtypes in AMD to optimize treatment outcomes.

Read the Vision Academy publication on characterization of MNV subtypes in AMD to optimize treatment outcomes

Elsewhere in the resource zone